Different Dual Approaches# Weight Loss Comparison# Cross-trial comparison is limited by differences in population, duration, dose escalation, and trial design
Beta Cell Protection One very small trial has suggested that a small dose of semaglutide could dramatically reduce the need for insulin in new type 1 diabetes patients
Before kicking off a new cycle, take a month-long break to minimize the risk of receptor desensitization
Blood Pressure & Lipids Patients on these therapies often see a significant drop in systolic blood pressure and improvements in their lipid panels (triglycerides and ApoB), likely due to improved insulin sensitivity
DPP-4 is a ubiquitous cell membraneassociated serine protease expressed in many tissues, including the gut (17, 18)
Moreover, pretreated cells displayed higher basal GCLC levels than cells without pretreatment, and the second NFT treatment led to a relatively modest additional increase (Fig